Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response
Copyright © 2023. Published by Elsevier Inc..
Melanoma, the cancer of the melanocyte, is the deadliest form of skin cancer with an aggressive nature, propensity to metastasize and tendency to resist therapeutic intervention. Studies have identified that the re-emergence of developmental pathways in melanoma contributes to melanoma onset, plasticity, and therapeutic response. Notably, it is well known that noncoding RNAs play a critical role in the development and stress response of tissues. In this review, we focus on the noncoding RNAs, including microRNAs, long non-coding RNAs, circular RNAs, and other small RNAs, for their functions in developmental mechanisms and plasticity, which drive onset, progression, therapeutic response and resistance in melanoma. Going forward, elucidation of noncoding RNA-mediated mechanisms may provide insights that accelerate development of novel melanoma therapies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:248 |
|---|---|
| Enthalten in: |
Pharmacology & therapeutics - 248(2023) vom: 27. Aug., Seite 108466 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Grafanaki, Katerina [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 14.07.2023 Date Revised 10.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.pharmthera.2023.108466 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358030730 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358030730 | ||
| 003 | DE-627 | ||
| 005 | 20240210232536.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.pharmthera.2023.108466 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1286.xml |
| 035 | |a (DE-627)NLM358030730 | ||
| 035 | |a (NLM)37301330 | ||
| 035 | |a (PII)S0163-7258(23)00130-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Grafanaki, Katerina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.07.2023 | ||
| 500 | |a Date Revised 10.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023. Published by Elsevier Inc. | ||
| 520 | |a Melanoma, the cancer of the melanocyte, is the deadliest form of skin cancer with an aggressive nature, propensity to metastasize and tendency to resist therapeutic intervention. Studies have identified that the re-emergence of developmental pathways in melanoma contributes to melanoma onset, plasticity, and therapeutic response. Notably, it is well known that noncoding RNAs play a critical role in the development and stress response of tissues. In this review, we focus on the noncoding RNAs, including microRNAs, long non-coding RNAs, circular RNAs, and other small RNAs, for their functions in developmental mechanisms and plasticity, which drive onset, progression, therapeutic response and resistance in melanoma. Going forward, elucidation of noncoding RNA-mediated mechanisms may provide insights that accelerate development of novel melanoma therapies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, N.I.H., Intramural | |
| 650 | 4 | |a Circular RNAs (circRNAs) | |
| 650 | 4 | |a Developmental state | |
| 650 | 4 | |a Lineage | |
| 650 | 4 | |a Long non-coding RNAs (lncRNAs) | |
| 650 | 4 | |a Melanoma | |
| 650 | 4 | |a Non-coding RNAs (ncRNAs) | |
| 650 | 4 | |a Plasticity | |
| 650 | 4 | |a Translational plasticity | |
| 650 | 4 | |a microRNAs (miRNAs) | |
| 650 | 7 | |a RNA, Untranslated |2 NLM | |
| 650 | 7 | |a MicroRNAs |2 NLM | |
| 650 | 7 | |a RNA, Long Noncoding |2 NLM | |
| 650 | 7 | |a RNA, Circular |2 NLM | |
| 700 | 1 | |a Grammatikakis, Ioannis |e verfasserin |4 aut | |
| 700 | 1 | |a Ghosh, Arin |e verfasserin |4 aut | |
| 700 | 1 | |a Gopalan, Vishaka |e verfasserin |4 aut | |
| 700 | 1 | |a Olgun, Gulden |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Huaitian |e verfasserin |4 aut | |
| 700 | 1 | |a Kyriakopoulos, George C |e verfasserin |4 aut | |
| 700 | 1 | |a Skeparnias, Ilias |e verfasserin |4 aut | |
| 700 | 1 | |a Georgiou, Sophia |e verfasserin |4 aut | |
| 700 | 1 | |a Stathopoulos, Constantinos |e verfasserin |4 aut | |
| 700 | 1 | |a Hannenhalli, Sridhar |e verfasserin |4 aut | |
| 700 | 1 | |a Merlino, Glenn |e verfasserin |4 aut | |
| 700 | 1 | |a Marie, Kerrie L |e verfasserin |4 aut | |
| 700 | 1 | |a Day, Chi-Ping |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacology & therapeutics |d 1981 |g 248(2023) vom: 27. Aug., Seite 108466 |w (DE-627)NLM000442402 |x 1879-016X |7 nnns |
| 773 | 1 | 8 | |g volume:248 |g year:2023 |g day:27 |g month:08 |g pages:108466 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pharmthera.2023.108466 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 248 |j 2023 |b 27 |c 08 |h 108466 | ||